Company intelligence / Profile preview

Chartex Resources

England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Chartex Resources was the original owner and manufacturer of the female condom technology, later acquired by The Female Health Company (now Veru); manufacturing operations ceased in 2009 per British labor law, after global commercialization efforts in partnership with organizations like WHO and USAID.

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: Device
Industry: Consumable Medical Devices

Partnerships

WHOUNAIDSUSAID

Beyond the preview

Go deeper on Chartex Resources.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chartex Resources.

Explore the full profile